PNC Financial Services Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301 | Buy |
+22
| New | +$301 | ﹤0.01% | 4755 |
|
|
2024
Q4 | – | Sell |
-500
| Closed | -$6.35K | – | 4927 |
|
|
2024
Q3 | $6.35K | Hold |
500
| – | – | ﹤0.01% | 3969 |
|
|
2024
Q2 | $8.39K | Sell |
500
-43
| -8% | -$722 | ﹤0.01% | 3835 |
|
|
2024
Q1 | $8.15K | Buy |
543
+542
| +54,200% | +$8.13K | ﹤0.01% | 3814 |
|
|
2023
Q4 | $15 | Buy |
+1
| New | +$15 | ﹤0.01% | 4603 |
|